Company Information
Industry 制造业
Company Introduction 浙江大洋生物科技集团股份有限公司成立于1976年,2003年转制为有限公司,2009年完成股份有限公司改制,拥有全资子公司4家。系国家高新技术企业、浙江省“守合同重信用”企业、浙江省清洁生产先进企业,公司于2016年挂牌新三板,股票简称:大洋生物,股票代码:837112。 公司主要从事钾盐、兽药、氟化工三大核心产业的生产经营,较早通过了ISO9001、ISO14001、ISO22000、OHSAS18001等国际体系认证。形成以碳酸钾、碳酸氢钾、氯化铵产品为主导,食品添加剂级、工业级、农业级等多规格系列化发展的产品群;高药效抗球虫盐酸氨丙啉产品通过美国FDA认证和兽药GMP体系认证,针对市场对盐酸氨丙啉用药要求不同,开发了具有高流动性、高品质、低杂质的系列产品。公司通过兽药GMP体系认证的兽药预混剂全部出口海外。含氟精细化学品主要有2-氯-6-氟苯甲醛等系列品种。产品坚持以国际化的战略思维谋发展,畅销全球几十个国家和地区。 公司设有两个省级技术研究院,新建一个博士后科研工作站,拥有多项专利技术,研发实力较强。主导起草国家碳酸钾技术标准、能耗标准,浙江省专利示范企业。 公司注重精益管理,坚持绿色生态优先,从源头上减少“三废”产生,实现末端治理向源头减排转变,对废物最大限度地进行资源化利用。秉承“拼博奋斗,开拓创新,同创共享,追求卓越”的核心价值观,坚持科学发展、绿色发展、创新发展的理念,矢志打造长青基业,持续为利益相关方及社会大众创造福祉。
Main Business 从事无机盐、兽用原料药等化学原料产品的生产和销售。
Legal Representative 陈阳贵
Top Executives
董事长:陈阳贵
副董事长:汪贤玉
董事:陈阳贵,汪贤玉,仇永生,关卫军,郝炳炎,王国平
独立董事:姜晏,韩秋燕,曾爱民
Top 5 Shareholder
Shareholder name Nature Holding Date
陈阳贵限售股+流通A股8.86%30/06/2024
汪贤玉限售股+流通A股4.80%30/06/2024
仇永生限售股+流通A股3.76%30/06/2024
涂永福限售股+流通A股2.93%30/06/2024
陈荣芳流通A股2.63%30/06/2024
Company Secretary 徐旭平
Solicitors 上海市锦天城律师事务所
Auditors 瑞华会计师事务所(特殊普通合伙)
Tel No 0571-64156868
Fax No 0571-64194030
Website www.dyhg.com
Email Xuxuping65@163.com;1355714860@qq.com
Company Address
Register: 浙江省杭州市建德市大洋镇朝阳路22号
Office: 浙江省杭州市建德市大洋镇朝阳路22号
Listing Date 26/10/2020
Shares Capital
Shares Capital: 84,000,000
Total A Share: 84,000,000
Listed A Share: 67,590,756
Non-tradable A Share: 16,409,244
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.619
DPS(RMB)* ¥ 0.850
NBV Per Share(RMB)* ¥ 12.002
Market Capitalization(RMB) 1.037B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.